[MCEMENT] YoY TTM Result on 31-Dec-2013 [#4]

Stock
[MCEMENT] MALAYAN CEMENT BERHAD
Announcement Date
25-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
QoQ- 1.37%
YoY- 5.05%
Quarter Report
Latest QR
Upcoming QR
MCEMENT's Result
MCEMENT's Financial Summary
View:
Show?
TTM Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 2,552,205 2,750,820 2,743,090 2,852,400 2,740,062 2,552,564 2,324,888 1.56%
PBT 74,281 346,906 345,183 514,890 469,752 414,647 345,397 -22.57%
Tax 3,448 -94,344 -89,176 -147,772 -120,262 -97,000 -54,301 -
NP 77,729 252,562 256,007 367,118 349,490 317,647 291,096 -19.73%
-
NP to SH 76,673 252,335 255,996 366,630 349,003 317,845 295,338 -20.11%
-
Tax Rate -4.64% 27.20% 25.83% 28.70% 25.60% 23.39% 15.72% -
Total Cost 2,474,476 2,498,258 2,487,083 2,485,282 2,390,572 2,234,917 2,033,792 3.31%
-
Net Worth 3,058,901 3,092,889 3,118,380 3,211,847 3,180,186 3,113,280 3,076,444 -0.09%
Dividend
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div 42,484 263,526 288,896 348,374 314,764 288,979 288,318 -27.30%
Div Payout % 55.41% 104.44% 112.85% 95.02% 90.19% 90.92% 97.62% -
Equity
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 3,058,901 3,092,889 3,118,380 3,211,847 3,180,186 3,113,280 3,076,444 -0.09%
NOSH 849,695 849,695 849,695 849,695 849,695 850,623 847,505 0.04%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 3.05% 9.18% 9.33% 12.87% 12.75% 12.44% 12.52% -
ROE 2.51% 8.16% 8.21% 11.41% 10.97% 10.21% 9.60% -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 300.37 323.74 322.83 335.70 321.38 300.08 274.32 1.52%
EPS 9.02 29.70 30.13 43.15 40.93 37.37 34.85 -20.15%
DPS 5.00 31.00 34.00 41.00 37.00 34.00 34.00 -27.32%
NAPS 3.60 3.64 3.67 3.78 3.73 3.66 3.63 -0.13%
Adjusted Per Share Value based on latest NOSH - 849,695
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 190.80 205.65 205.07 213.24 204.84 190.82 173.80 1.56%
EPS 5.73 18.86 19.14 27.41 26.09 23.76 22.08 -20.11%
DPS 3.18 19.70 21.60 26.04 23.53 21.60 21.55 -27.28%
NAPS 2.2868 2.3122 2.3312 2.4011 2.3774 2.3274 2.2999 -0.09%
Price Multiplier on Financial Quarter End Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 7.19 8.88 9.76 8.57 9.62 7.00 7.67 -
P/RPS 2.39 2.74 3.02 2.55 2.99 2.33 2.80 -2.60%
P/EPS 79.68 29.90 32.40 19.86 23.50 18.73 22.01 23.89%
EY 1.26 3.34 3.09 5.03 4.26 5.34 4.54 -19.22%
DY 0.70 3.49 3.48 4.78 3.85 4.86 4.43 -26.45%
P/NAPS 2.00 2.44 2.66 2.27 2.58 1.91 2.11 -0.88%
Price Multiplier on Announcement Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 22/02/17 29/02/16 26/02/15 25/02/14 20/02/13 22/02/12 23/02/11 -
Price 6.49 9.08 10.40 8.54 9.19 7.37 7.32 -
P/RPS 2.16 2.80 3.22 2.54 2.86 2.46 2.67 -3.46%
P/EPS 71.92 30.58 34.52 19.79 22.45 19.72 21.01 22.74%
EY 1.39 3.27 2.90 5.05 4.45 5.07 4.76 -18.53%
DY 0.77 3.41 3.27 4.80 4.03 4.61 4.64 -25.84%
P/NAPS 1.80 2.49 2.83 2.26 2.46 2.01 2.02 -1.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment